Holen Sie sich die Stockscreener-App
10.02
1.57%
-0.16
Vorhandelsmarkt:
9.96
-0.06
-0.60%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TPST?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$10.18
Offen:
$10.25
24-Stunden-Volumen:
44,971
Relative Volume:
0.80
Marktkapitalisierung:
$44.49M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-43.10M
KGV:
-1.0307
EPS:
-9.7212
Netto-Cashflow:
$-36.82M
1W Leistung:
-8.99%
1M Leistung:
-3.65%
6M Leistung:
+43.35%
1J Leistung:
-15.24%
1-Tages-Spanne:
$9.81
$10.45
1-Wochen-Bereich:
$9.81
$11.12
52-Wochen-Spanne:
$5.3495
$15.08
Tempest Therapeutics Inc Stock (TPST) Company Profile
Firmenname
Tempest Therapeutics Inc
Sektor
Branche
Telefon
415-798-8589
Adresse
2000 SIERRA POINT PARKWAY, BRISBANE
Vergleichen Sie TPST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
10.02 | 45.20M | 0 | -43.10M | -36.82M | -9.7212 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-10 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-04-10 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-02-08 | Eingeleitet | Jefferies | Buy |
Tempest Therapeutics Inc Aktie (TPST) Neueste Nachrichten
Will Tempest Therapeutics Inc. benefit from macro trendsJuly 2025 Levels & Real-Time Stock Movement Alerts - newser.com
Why Tempest Therapeutics Inc. stock is seen as undervaluedEntry Point & Smart Investment Allocation Insights - newser.com
Can technical indicators confirm Tempest Therapeutics Inc.’s reversalWeekly Earnings Recap & Real-Time Market Sentiment Alerts - newser.com
Why Tempest Therapeutics Inc. stock appeals to dividend seekersWeekly Trend Recap & High Return Trade Opportunity Guides - newser.com
Is Tempest Therapeutics Inc. meeting your algorithmic filter criteria2025 Performance Recap & Fast Entry High Yield Tips - newser.com
Why Tempest Therapeutics Inc. stock could be next big winnerJuly 2025 PreEarnings & Low Risk High Reward Ideas - newser.com
Building trade automation scripts for Tempest Therapeutics Inc.Market Activity Report & Safe Investment Capital Preservation Plans - newser.com
Tempest Therapeutics Inc.’s volatility index tracking explainedJuly 2025 PostEarnings & Step-by-Step Swing Trade Plans - newser.com
Ranking Tempest Therapeutics Inc. among high performing stocks via toolsJuly 2025 Movers & Breakout Confirmation Trade Signals - newser.com
Is Tempest Therapeutics Inc. stock cheap at current valuationMarket Activity Report & Safe Capital Allocation Plans - newser.com
Full technical analysis of Tempest Therapeutics Inc. stockBond Market & Real-Time Stock Price Movement Reports - newser.com
Can trapped investors hope for a rebound in Tempest Therapeutics Inc.Weekly Trade Recap & Breakout Confirmation Alerts - newser.com
Is Tempest Therapeutics Inc. stock undervalued vs historical averagesMarket Performance Recap & AI Driven Stock Price Forecasts - newser.com
How Tempest Therapeutics Inc. stock performs in interest rate cyclesJuly 2025 Short Interest & Smart Money Movement Alerts - newser.com
Will Tempest Therapeutics Inc. stock outperform Nasdaq indexJuly 2025 EndofMonth & Long-Term Safe Investment Ideas - newser.com
Using flow based indicators on Tempest Therapeutics Inc.2025 Historical Comparison & Long-Term Capital Growth Strategies - newser.com
What momentum indicators show for Tempest Therapeutics Inc. stock2025 Technical Overview & Daily Momentum Trading Reports - fcp.pa.gov.br
Finanzdaten der Tempest Therapeutics Inc-Aktie (TPST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):